A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2006
11/22/2006	CN1867341A Compositions for controlling parasites comprising a combination of abamectin and milbemycin
11/22/2006	CN1867325A Jelly pharmaceutical preparation containing biguanide-based medicine
11/22/2006	CN1867321A A solid dosage form comprising a fibrate
11/22/2006	CN1867320A Monodispersed solid lipid particle compositions
11/22/2006	CN1867252A Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
11/22/2006	CN1865287A Disintegrator carboxymethylstarch sodium preparation method
11/22/2006	CN1864822A Separating film for removing carbon monoxide, separating film assembly, method of removing carbon monoxide from an oxygen carrier and apparatus for removing carbon monoxide, oxygen carrier and its pha
11/22/2006	CN1864749A A pharmaceutical composition and preparation method thereof
11/22/2006	CN1864696A New formulation
11/22/2006	CN1864672A A solid dispersion of ambroxol hydrochloride and composition thereof
11/22/2006	CN1864667A A stable lyophilized preparation of rocuronium bromide and preparation method thereof
11/22/2006	CN1864666A Lyophilized powder injection of levofloxacin mesylate and preparation method thereof
11/22/2006	CN1864665A Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
11/22/2006	CN1864664A Lmiquimod cream and preparation method thereof
11/22/2006	CN1864663A Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2 (11),3,5,7,9-pentaene
11/22/2006	CN1864662A A triptolide composite preparation for treating osteoarthritis by joint intracavity injection
11/22/2006	CN1285582C Thioflavin derivatives for alzheimer's disease premortal diagnosis and starch-like protein in vivo image forming and precaution
11/22/2006	CN1285382C Nasal administered drug delivery system containing mycose and hyaluronic acid and method for preparing same
11/22/2006	CN1285347C Kuhseng-targeting preparation and its preparing method
11/22/2006	CN1285333C Colon target releasing oral preparation and its preparing method
11/21/2006	US7138546 Compounds and compositions for delivering active agents
11/21/2006	US7138520 Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
11/21/2006	US7138517 Sugar modified oligonucleotides
11/21/2006	US7138501 Antibodies that immunospecifically bind BLyS
11/21/2006	US7138490 of polyethylene glycols and polylactams with an impurities content of not more than 10% by weight; complex of polymer and an anthracycline anticancer drug, such as doxorubicin
11/21/2006	US7138431 Dietary control of arachidonic acid metabolism
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138394 Vehicle for topical delivery of anti-inflammatory compounds
11/21/2006	US7138390 3 alpha ,7 alpha -dihydroxy-6 alpha -ethyl-5 beta -cholan-24-oic acid and salts, solvates or amino acid conjugates thereof; treatment of a farnesoid X receptor mediated disease such as hypercholesteremia, hyperlipidemia, low HDL-cholesterol, and high triglycerides
11/21/2006	US7138387 Clear aqueous composition comprising propofol and hydroxypropyl-beta-cyclodextrin
11/21/2006	US7138381 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138244 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
11/21/2006	US7138146 Acrochordon alleviation
11/21/2006	US7138142 Producing isoleucine, leucine and valine containing particles having reduced bitterness and odor; small volume dose
11/21/2006	US7138138 Pharmaceutical formulation having a masked taste and method for the production thereof
11/21/2006	US7138136 Biocompatible particles between 0.1 and 1.0 microns in diameter, that are loaded with one or more drugs and which are crosslinked together to form agglomerates
11/21/2006	US7138135 blend of anionic and nonionic water soluble hydroxyl functionalized polymer; pH insensitivity
11/21/2006	US7138134 Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
11/21/2006	US7138133 Orally administered liquid compositions
11/21/2006	US7138132 Hydrogel entrapping therapeutic agent and stent with coating comprising this
11/21/2006	US7138129 Skin care compositions
11/21/2006	US7138127 Clostridial toxin derivatives and methods for treating pain
11/21/2006	US7138122 Therapeutic systems
11/21/2006	US7138121 Biosensors utilizing dendrimer-immobilized ligands and there use thereof
11/21/2006	US7138114 Pharmaceutical compositions of fibrinolytic agent
11/21/2006	US7138106 Compositions for use in embolizing blood vessels
11/21/2006	US7138105 Compositions for delivery of therapeutics and other materials, and methods of making and using the same
11/21/2006	US7138103 Completitive binding
11/21/2006	CA2478621C Botulinum toxin pharmaceutical compositions
11/21/2006	CA2351720C Taste masking rapid release coating system
11/21/2006	CA2338753C Medicinal aerosol formulations
11/21/2006	CA2318260C Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
11/21/2006	CA2199140C Probiotic compositions
11/20/2006	CA2508095A1 Preparation for external use on skin
11/20/2006	CA2508094A1 Composition for accelerating collagen synthesis
11/16/2006	WO2006122223A2 Strategies for delivery of active agents using micelles and particles
11/16/2006	WO2006121429A1 Clindamycin compositions and delivery system therefor
11/16/2006	WO2006121384A1 Method of improving immune function in mammals using 3-hpa producing lactobacillus strains in combination with medium chain triglyceride oil
11/16/2006	WO2006121199A1 Lipid liposome composition
11/16/2006	WO2006121156A1 Medical composition for promotion of skin regeneration
11/16/2006	WO2006121098A1 Soft capsule film composition
11/16/2006	WO2006121007A1 Degradable polymer and process for production thereof
11/16/2006	WO2006120973A1 Gel sheet for protecting skin
11/16/2006	WO2006120915A1 Agent for improving circulatory disorder
11/16/2006	WO2006120456A1 Pharmaceutical formulations of hdac inhibitors
11/16/2006	WO2006120382A1 Synthetic receptor
11/16/2006	WO2006120003A1 Isoalkane mixture, its preparation and use
11/16/2006	WO2006119692A1 A medicament for the treatment of hypertension
11/16/2006	WO2006119643A1 Anti-ocular angiogenesis molecules and their uses
11/16/2006	WO2006119619A1 Oligonucleotides inhibiting cell proliferation
11/16/2006	WO2006091332A3 Intranasal administration of active agents to the central nervous system
11/16/2006	WO2006051103A3 Stable formulations of peptides
11/16/2006	WO2006029183A3 Compositions and methods for the diagnosis and treatment of tumor
11/16/2006	WO2006002895A3 Conjugates of antibody and duoarmycin derivatives as antitumor agents
11/16/2006	WO2005067976A3 Direct compression formulation and process
11/16/2006	WO2005048977A3 Therapeutic foam comprising a sclerosing solution
11/16/2006	WO2002094236A9 Delivery of antipsychotics through an inhalation route
11/16/2006	US20060258841 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/16/2006	US20060258835 Implantable or ingestable medical device made of a polyesterether copolymer derived from an aromatic diacid, an aliphatic diacid, a polyalkylene glycol and a diol, for example, terephthalic acid, succinic acid, polyethylene glycol and butanediol; tissue engineering, sutures for example
11/16/2006	US20060258617 Drug delivery to the back of the eye
11/16/2006	US20060258602 Site-specific gene conversion promoter and gene therapeutic
11/16/2006	US20060258601 Formulation for inwardly transferring nucleic acids into eucaryotic cells
11/16/2006	US20060258587 Modified MscL protein channel
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060258575 Sustained-release microparticle preparation of human growth hormone and process for producing thereof
11/16/2006	US20060258570 Decorin proteoglycan inhibitor of fibrinogen blood clotting
11/16/2006	US20060258569 Compounds and methods for treating cancer
11/16/2006	US20060258566 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/16/2006	US20060258537 etherification of cyclodextrin using hydroxy(C2-C6 alkylene)-sulfonic acid sodium salt and hydroxyalkyl compound; can be used to solubilize compounds with insufficient water solubility; osmotic agents, agents used to mask the taste of problematic drugs
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257504 Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use
11/16/2006	US20060257476 Tablet formulation
11/16/2006	US20060257463 Transmucosal delivery of cannabinoids
11/16/2006	US20060257459 Carrier
11/16/2006	US20060257454 Conjugated fatty acid esters
11/16/2006	US20060257453 Powderous formulations of fat-soluble active ingredients
11/16/2006	US20060257433 Formulation
11/16/2006	US20060257419 Bordetella pertussis antigen consisting lipopolysaccharide, pertusis toxin, filamentous hemagglutinin, pertactin or abosrbed to alum; interleukin-12 ; enhances cell-mediated immunity in a host
11/16/2006	US20060257330 Powdery pharmaceutical compositions for inhalation

1 ... 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 ... 1712